Sandoz Inc., the generic pharmaceutical division of Novartis, has launched the generic version of cyclophosphamide injection, USP, an anti-cancer drug in the US. Sandoz is launching cyclophosphamide injection, USP, through collaboration with Jiangsu ... Individual.com, 3 days ago
2 images for "sandoz inc"
Sandoz Inc. has received marketing authorizations from the pharmaceutical regulatory authorities in Estonia, Latvia and Lithuania for AirFluSal Forspiro, a new inhaler for patients with asthma and/or chronic obstructive pulmonary disease, or COPD.Individual.com, 4 days ago
Apricus Biosciences, Inc., a biopharmaceutical company, has announced the launch of Vytaros, for treatment of erectile dysfunction, in Belgium by the Sandoz Division of the Novartis Group of Companies. Apricus' novel topical on-demand treatment for ...Individual.com, 1 week ago Anacor Pharmaceuticals to Present at the 2014 Credit Suisse Healthcare Conference BioSpace, 2 weeks ago Momenta Pharmaceuticals Reports Third Quarter 2014 Financial Results Benzinga.com, 2 weeks ago Anacor Pharmaceuticals : to Present at the 2014 Credit Suisse Healthcare Conference 4 Traders, 2 weeks ago
Medigene AG announces that its US licensee, Fougera Pharmaceuticals Inc, a Sandoz company, has signed a promotion agreement with Women's Choice Pharmaceuticals LLC (WCP), a specialty pharmaceutical company based in Gilbert, Arizona, for Veregen ...PharmaBiz, 2 weeks ago MEDIGENE : Licensee enters promotion agreement to expand Veregen® product sales in the United States 4 Traders, 3 weeks ago Medigene's Licensee enters promotion agreement to expand Veregen® product sales in the United States Yahoo! UK and Ireland, 3 weeks ago MEDIGENE' : Licensee enters promotion agreement to expand Veregen® product sales in the United States 4 Traders, 3 weeks ago
October 30, 2014 By Riley McDermid , BioSpace.com Breaking News Sr. Editor The battle over biosimilars is just beginning and the skirmish between biotechs Amgen ( AMGN ) and Sandoz is creating some fascinating legal problems, said ...BioSpace, 3 weeks ago Amgen/Sandoz Disputes Will Clarify BPCIA (Biologics Price Competition and Innovation Act) Issues National Law Review, 1 week ago Sandoz and Celltrion Decline the Invitation to Dance: Biosimilars Challenge the Applicability of the BPCIA's Exchange Provisions Before Bringing Suit JD Supra, 1 week ago
TRENTON, N.J., Nov. 6 -- The New Jersey Economic Development Authority issued the following news release: Showcasing New Jersey's continued ability to retain life-science companies, Lt. Governor Kim Guadagno today joined executives from Sandoz, ...Pharmaceutical & Medical Packaging News, 1 week ago Novartis : Lt. Governor Guadagno Celebrates Grand Opening of Sandoz, Inc.'s New U.S. Headquarters 4 Traders, 2 weeks ago
the Supreme Court heard oral arguments in , regarding the proper standard of review for patent claim constructions. Although de novo review of district court claim constructions has been the US Court of Appeals for the Federal Circuit's modus ...Intellectual Property Magazine, 1 week ago Oral Argument In Teva Pharmaceuticals: Supreme Court To Decide Federal Circuit's Standard Of Review Of District Court Claim Construction Rulings JD Supra, 3 weeks ago
Case Name: , Civ. Nos. 12-cv-01617, 13-cv-316, 2014 U.S. Dist. LEXIS 121573 (D.N.J. Aug. 29, 2014) (Sheridan, J.) Drug Product and Patent(s)-in-Suit: Remodulin® (treprostinil sodium); U.S. Patents Nos. 6,576,117 (the 117 patent) and 7,999,007 ...JD Supra, 1 month ago
Harvard Bioscience, Inc., a manufacturer of scientific instruments and apparatus, has elected Bertrand Loy to its board of directors. Mr Loy is President and CEO of Entegris Inc., a provider of yield-enhancing materials and solutions used in ...Individual.com, 1 week ago
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has promoted Patrick Vink, current senior vice president and general manager of the company's international business, to the role of executive vice president, or EVP, and COO, effective ...Individual.com, 1 week ago Cubist Names Dr. Patrick Vink Chief Operating Officer CNBC, 2 weeks ago Cubist Pharmaceuticals : Names Dr. Patrick Vink Chief Operating Officer 4 Traders, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!